Home > Boards > US OTC > Medical - Equipment > Ozop Surgical Corp. (OZSC)

OZSC OZOP SURGICAL EXECUTIVE MANAGEMENT TEAM

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sharky Member Profile
Member Level 
Followed By 1,371
Posts 102,249
Boards Moderated 6
Alias Born 01/22/04
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 4:39:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 4:14:19 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 10/15/2019 8:02:20 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/7/2019 5:15:09 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 10/4/2019 4:14:27 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/2/2019 6:00:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2019 4:02:22 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 9/19/2019 5:18:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2019 8:07:03 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 9/16/2019 8:52:49 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/26/2019 9:04:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2019 5:23:42 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/19/2019 2:49:08 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/15/2019 4:07:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2019 4:27:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/10/2019 5:14:24 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 6/28/2019 10:35:02 AM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 6/14/2019 4:05:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2019 5:12:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2019 4:48:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2019 5:20:39 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 5:40:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/9/2019 5:12:37 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2019 4:40:35 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/16/2019 5:22:03 PM
sharky Member Level  Thursday, 10/17/19 12:15:10 PM
Re: None
Post # of 1578 
OZSC OZOP SURGICAL EXECUTIVE MANAGEMENT TEAM

Michael Chermak, CEO, Chairman
CONTACT
Michael Chermak has over 30 years of experience in healthcare-related ventures. Previously, he was the founder and CEO of Healthdemographics, Inc., a company in the healthcare predictive data and decision support business. Healthdemographics had over 1,200 clients worldwide and was regularly cited by the Wall Street Journal in articles about the healthcare industry. He sold the company in 1997 to Medirisk.

In 1998, he was the co-founder, initial investor, and original Chairman of Medibuy.com, an Internet healthcare supply vendor. Medibuy raised over $140 million in its first 18 months of operation backed by leading VCs such as Kleiner Perkins, Sequoia, Oak, and institutional investors including Alianz. Medibuy acquired the ecommerce initiatives of two leading GPOs, Premier and Columbia HCA, that at one time accounted for nearly 70% of healthcare product expenditures in the US. Medibuy was sold to GHX (Global Health Exchange), an ecommerce company founded by General Electric, Abbot, Baxter, Medtronic. Becton-Dickinson, Braun, Guidant, Tyco, Siemens, and others.

He worked in China for over 6 years and was the former Chairman and CEO of Bridgetech Holdings International (OTC: BGTH), which focused on introducing Western medicine into China. He has served on the Board of Directors and as an Audit Committee member of Beijing Origin Seed (NASDAQ: SEED).

Michael graduated from the University of New Mexico, Anderson School of Management. Michael and his wife fund and run a 501(c)(3) focused on animal rescue and the support of rescue organizations.

Tom McLeer, Chief Operating Officer, Director
CONTACT
Tom McLeer brings over 30 years of commercial operations experience in orthopedics, spine and orthobiologics. He is a proven medical device leader who has boosted sales for existing companies and led startups through regulatory approval and into full commercialization. He holds numerous patents in the spine and orthopedic space.

He most recently served as Vice President of Sales and Marketing at LinkSpine. Previously he was Senior Vice President of US Commercial Operations for Alphatec Spine, Global CMO and General Manager of Spinal Operations for Pioneer Surgical (sold to RTI) and VP of Sales and Marketing for Archus Orthopedics. Earlier in his career, McLeer was VP of Marketing and Business Development for Spinal Concepts (sold to Abbott labs) and VP of Marketing for Interpore Cross International.

Tom holds a B.S. in Business Administration from The Ohio State University and a MBA from the Kellogg School of Management at Northwestern University.

Barry Hollander, Chief Financial Officer
CONTACT
Barry Hollander has 38 years of business experience, including 20 years as Chief Financial Officer of various private and public companies. In 2010, Mr. Hollander founded Venture Equity, LLC, a Florida-based company that offers financial and business consulting services. He was named Chief Financial Officer of Cabinet Grow, Inc. (“CBNT”) on May 14, 2014, and is also the current CEO of CBNT. Since 2011, Mr. Hollander has been the Chief Financial Officer of Agritek Holdings, Inc. (“Agritek”), formerly known as MediSwipe, Inc. Agritek provides real estate management and health and wellness product lines for the medicinal marijuana industry.

Barry began his career in 1981 in the accounting department of Macgregor Sporting Goods, and rose through the ranks to become a critical part of the executive management team. Over his career, Barry contributed to mergers and acquisitions, assisting companies preparing to go public and taking on public reporting responsibilities. He holds a degree from Fairleigh Dickinson University.

Nick Ansari, Executive Vice President, Sales & Marketing
CONTACT
Nick Ansari has more than 25 years of experience in the medical device field. Over the course of his career, he has amassed an impressive track record in defining strategies and executing initiatives that drive revenue and strengthen market shares for startup, turnaround, and rapid-growth medical device companies. Nick has an in-depth understanding of markets, products, customers, and competitors, which helps him deliver strategic and tactical blueprints to ensure success in US and international environments. He leverages his comprehensive experience in business development, P&L management, strategic planning, forecasting, sales force leadership, asset analysis, product training, and market expansion to exceed projections time and again.

Nick has previously held senior leadership positions in various medical device companies, including Stryker, Medtronic, Globus, and Lanx/Biomet-Zimmer. As an executive-level team player, he has assisted mergers and acquisitions in the private and public medical device sectors—namely, when Biomet, ZBH purchased Lanx ($147 million); when RSLS, Reshape Lifesciences purchased Bario Surge; and when RSLS purchased Lap-Band from Apollo Endosurgery, APEN.

Eric Siu, Director of Endoscopic Program Development
Eric Siu has been focused on endoscopic surgical approaches for more than 25 years. He has spent over a decade creating IP and developing minimally invasive endoscopic products, including four different neuroendoscopic systems (Viewing Endoscope, Pituitary Endoscope, Intraventricular Endoscope, Subcortical Space endoscope with visible tube) and four types of spine endoscopes (MED, MED with retractor, PELD and Cervical). Eric currently holds dozens of patents in the PRC and abroad.

OZOP is an extension of his expertise on Spine and Neuro endoscopes; and his focus on molecular MIS recognizes the future potential for endoscope systems. His experience in product development and in the laboratory add stability and bring tremendous value to the company as it pursues its great future.

Eric has established academic research collaborations with the Chinese University of Hong Kong and Hong Kong University as well as leading institutions in the PRC. He has a long history of collaboration with the MOH (Ministry of Health), where he has organized over 200 workshops for leading Chinese surgeons working with international medical device manufacturers as well as the CDA (Chinese Doctors Association) regarding physician and surgeon training and continuing education initiatives. He also has extensive experience in working with China’s regulatory body, the CFDA, and has successfully registered over 100 products for international medical devices manufacturers.

Eric has maintained an office in Tuttlingen, Germany for over 15 years; from that location, he has sourced products for introduction and sale in the PRC. Eric, a Canadian citizen based in Hong Kong and Beijing, holds degrees in Applied Mathematics and Physics from the University of London.



$OZSC


Surrounded by thieves, lets fight our way out!


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist